SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ProMetic Life Sciences
An SI Board Since April 2016
Posts SubjectMarks Bans Symbol
250 11 0 PLI.TO
Emcee:  axial Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
175PROMETIC ANNOUNCES PUBLICATION OF PBI-4050’s NOVEL ANTIFIBROTIC MECHANISM OF ACTaxial-2/16/2018
174PROMETIC GRANTED ORPHAN DRUG DESIGNATION BY FDA FOR INTER-ALPHA-INHIBITOR-PROTEaxial-2/15/2018
173Thanks Jim. That is a very impressive and informative presentation. In a preCush-2/1/2018
172KOL MEETING: PBI 4050 -- NOTES (1) — Must listen. Very significant presentatioaxial12/1/2018
171Prometic Therapeutics Plasma-Derived Therapeutics Through developing industraxial-1/29/2018
170Preliminary comments — PHASE 3 PIVOTAL CLINICAL TRIAL FOR IDIOPATHIC PULMONARY Faxial11/29/2018
169PROMETIC’S PBI-4050: PHASE 3 PIVOTAL CLINICAL TRIAL DESIGN FOR IDIOPATHIC PULMONaxial21/29/2018
168PROMETIC TO HOST KEY OPINION LEADER MEETING ON NOVEL TREATMENTS FOR IDIOPATHIC Paxial-1/25/2018
167New Prometic videos — [1] Virtual Tour of Prometic Life Science's Manufactaxial-1/4/2018
166Not bad ... [graphic] Jimaxial11/4/2018
165A cheer for the prosperous New Year!Leo Fisher-12/25/2017
164Thanks Jim. Merry Christmas to you, too! And may we all have a Happy, Healthy, Cush-12/25/2017
163Cush, to you and our other readers: be well in 2018. Merry Christmas! Jaxial-12/25/2017
162Followup — No content changed. Edited for clarity. A few questions on latest PRaxial112/20/2017
161Yes, I agree Jim. The next six months are going to be very interesting. HaveCush-12/19/2017
160Hi Cush — Sometime soon, we should discuss off-label uses for PBI-4050 and Ryplaaxial112/19/2017
159PROMETIC’S PLASMINOGEN (RYPLAZIM™) GRANTED ORPHAN DRUG DESIGNATION FOR THE TREATCush112/18/2017
158PROMETIC’S PBI-4050 RECEIVES PROMISING INNOVATIVE MEDICINE (PIM) DESIGNATION FRaxial-12/11/2017
157PIVOTAL DATA FOR PROMETIC’S INTRAVENOUS PLASMINOGEN REPLACEMENT THERAPY TO BE PRaxial-12/6/2017
156BNN videos, recent — What's next for Prometic Life Sciences ProMetic Lifaxial-12/5/2017
155Thanks, Leo — "Dilutions do hurt a bit". Agreed. As many have noted,axial-12/3/2017
154Jim, Thanks for the continuous updates! Still holding strong. Dilutions do hurtLeo Fisher-12/3/2017
153PROMETIC ANNOUNCES THE CLOSING OF ITS USD $80 MILLION (CAD $100 MILLION) LINE Oaxial-12/1/2017
152PROMETIC REPORTS POSITIVE INTERIM CLINICAL DATA FROM ONGOING INTRAVENOUS IMMUNOaxial-12/1/2017
15130 Nov 2017: Recent analyst reports — http://docdro.id/n1DzGTN Hat tip: saxial-11/30/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News